Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
Holding ADAP?
Track your performance easily

Adaptimmune Therapeutics (ADAP) Similar Stocks

797 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Adaptimmune Therapeutics
$198.66M
-2.24
38.08%
3 Buy
2 Hold
1 Sell
Moderate Buy
Affimed
$58.32M
-1.38
1.05%
2 Buy
1 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$179.94M
-2.33
71.89%
5 Buy
0 Hold
0 Sell
Strong Buy
Cellectis SA
$131.27M
-1.70
-30.00%
3 Buy
0 Hold
0 Sell
Strong Buy
Fate Therapeutics
$290.39M
-1.49
9.44%
3 Buy
9 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ADAP
Adaptimmune Therapeutics
0.78
0.23
41.82%
AFMD
Affimed
3.83
0.31
8.81%
BDTX
Black Diamond Therapeutics
3.18
1.38
76.67%
CLLS
Cellectis SA
1.75
-0.65
-27.08%
FATE
Fate Therapeutics
2.55
0.42
19.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis